Gregory D Davis Sangamo Therapeutics, Inc (SGMO) insider trading activity
Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 201,945 shares of SGMO, which is worth approximately $105,011. The most recent transaction as insider was on Jul 22, 2025, when has been sold 6,708 shares (Common Stock) at a price of $0.48 per share, resulting in proceeds of $3,219. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
202K
3.55%
3M change
n/a
12M change
Total Value Held
$105,011
Gregory D Davis Transaction History
GDD
Gregory D Davis
Head of Research & Technology
Richmond, CA